
International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
Conferences Published ↓
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 7 Issue 2
March-April 2025
Indexing Partners



















Living with Cancer: The Association between Disease Duration and Quality of Life Outcomes, a Cross sectional study
Author(s) | Jeseena K |
---|---|
Country | India |
Abstract | Background Cancer patients' quality of life (QOL) is an important measure that affects both their general health and responses to treatment. Assessing the effect of cancer duration on patients' quality of life is the aim of this study. Methodology QOL in cancer patients was measured in a cross-sectional study using a four-point Likert-type rating scale. The QOL scores were classified as average, above average, significantly high, below average, and significantly poor. Appropriate statistical tests were applied in the statistical analysis and p value<0.05 is taken as significant Results The QOL was higher for patients who had been diagnosed for less than six months. On the other hand, QOL significantly declined as cancer duration progressed. Of those who had cancer for more than 36 months, only 17.3% had an average quality of life (QOL), whereas 44.8% had significantly poor QOL.These correlations were found to be statistically significant(p<0.05) Conclusion QOL is adversely affected by the course of cancer; longer disease duration is linked to a lower quality of life. Cancer patients may benefit from early therapies to retain a higher quality of life. |
Keywords | Key Words- QOL,Cancer,Duration,Tertiary centre,Jharkhand |
Field | Medical / Pharmacy |
Published In | Volume 7, Issue 2, March-April 2025 |
Published On | 2025-03-13 |
DOI | https://doi.org/10.36948/ijfmr.2025.v07i02.38843 |
Short DOI | https://doi.org/g895rz |
Share this

E-ISSN 2582-2160

CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
